Oral Dexmedetomidine for Parental Separation in Pediatrics Undergoing Adenotonsillectomy

NCT03551067 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2018-07-05

No results posted yet for this study

Summary

The efficacy of oral dexmedetomidine as sedative versus a combination of oral midazolam plus oral ketamine were compared regarding to satisfactory separation from parents, satisfactory mask induction and postoperative rescue analgesia in Pediatrics undergone Adenotosillectomy

Conditions

  • Adenotonsillectomy

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine mixed with juice was given to the child orally preoperatively.

COMBINATION_PRODUCT

Midazolam/Ketamine

Midazolam/Ketamine was mixed with juice and given to the child orally preoperatively

Sponsors & Collaborators

  • Suez Canal University

    lead OTHER

Principal Investigators

  • Mohamed Elsadany, MD · Suez Canal University

  • Ghada Kamhawy, MD · Suez Canal University

  • Reda mohmd, MD · Suez Canal University

  • Mohamed Abdelgawad, MD · Suez Canal University

  • Ahmed Elewa, MD · Suez Canal University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-01
Primary Completion
2017-12-15
Completion
2018-01-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03551067 on ClinicalTrials.gov